Users Discontinuing Weight-Loss Medications Gain Back Weight at a Quadrupled Rate Compared to Dieters

A recent study suggests that people who stop using blockbuster GLP-1 drugs like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who halt traditional lifestyle regimens.

Findings released in a leading health publication shows that while overweight individuals often shed about a fifth of their total mass while using the jabs, the mass is regained at an average rate of nearly a kilo each month once they quit.

"People using these medications need to be cognizant of the risk of quick weight regain when the treatment concludes," warns expert Dr. Susan Jebb.

This pace of regain means a reversion to original weight in about one and a half years.

Analyzing Therapies

The research, which reviewed dozens of trials involving thousands of participants, contrasted the effects of the injectable medications with older methods.

The team emphasize that people who shed pounds through diet and exercise usually see a more gradual weight regain—perhaps 100 grams monthly—post-intervention.

Explaining the Fast Regain

Doctors suggest the mechanism of the injections explains the amplified rebound.

GLP-1 drugs mimic a body's own chemical called GLP-1, which controls appetite.

"Sustained high doses of GLP-1 levels far above than normal may cause the system to produce less of its endogenous hormone, and could reduce responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this hormone supplement means hunger is unsuppressed, making excessive eating far more likely."

A Lifelong Disease?

Health authorities advise the jabs for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Professionals contend that, due to the likelihood of weight regain, the treatment might need to be long-term.

This view is echoed by drug manufacturers, who say that the results "emphasize the long-term character of obesity," akin to managing diseases like high blood pressure.

User Accounts

Individuals who have stopped the medication explain a intense return of appetite.

"It was like a trigger that goes on and I was suddenly extremely hungry," recalled an individual.

This difficulty is worsened if patients have not established sustainable lifestyle or habit modifications during therapy.

Growing Adoption

Recent estimates show that a significant number of adults in the UK have used weight-loss jabs in the past year, with desire continuing to grow.

• Use is greater among women than men.
• The middle-aged age group shows the greatest usage rates.
• A large proportion obtain the drugs through private healthcare rather than the NHS.

Finally, clinicians caution that while GLP-1 drugs are powerful agents for weight loss, they are not a magic solution and maintained weight loss hinges on integrated lifestyle support.